Please login to the form below

Not currently logged in
Email:
Password:

genetic testing

This page shows the latest genetic testing news and features for those working in and with pharma, biotech and healthcare.

FDA approves another home genetic testing service

FDA approves another home genetic testing service

FDA approves another home genetic testing service. 23andMe’s kit will check for an increased risk of certain cancers developing. ... The US Food and Drug Administration (FDA) has authorised another one of 23andMe’s home genetic kits, and this one

Latest news

  • Lundbeck partners with 23andMe on first-of-its-kind study Lundbeck partners with 23andMe on first-of-its-kind study

    To this end, we expect the study to provide detailed insights into the interaction of mood symptoms, cognitive processes and environmental factors, and to link these factors to genetic data. ... changed its mind on 23andMe’s genetic testing kits.

  • FDA changes its mind on 23andMe's genetic testing kits FDA changes its mind on 23andMe's genetic testing kits

    FDA changes its mind on 23andMe's genetic testing kits. Approves a home test kit for gene sequences related to diseases like Alzheimer’s and Parkinson’s. ... what is expected to open the door for more direct-to-consumer (DTC) genetic test approvals.

  • EC approves Bial’s Parkinson’s disease therapy EC approves Bial’s Parkinson’s disease therapy

    Last year the Google-backed genetic testing company 23andMe signed a $60m research deal with Roche subsidiary Genentech to generate whole genome sequencing data for about 3, 000 people with

  • Roche buys gene sequencing firm Roche buys gene sequencing firm

    Roland Diggelmann, who is chief operating officer of Roche's diagnostics division, said adding Kapa to its portfolio would allow the company to offer "complete genetic testing" to its customers.

  • Just manufacturing pills ‘no longer good enough for patients’ Just manufacturing pills ‘no longer good enough for patients’

    23andMe, the US-based genetic and diagnosis home testing kit company has also signed multiple deals with big pharma firms, including Pfizer and Roche/Genentech, to help understand certain therapy areas

More from news
Approximately 3 fully matching, plus 29 partially matching documents found.

Latest Intelligence

  • Harnessing the power of genetics Harnessing the power of genetics

    Collaboration and data management offer huge potential for improving testing and analysis and the subsequent provision of advice to patients. ... Routine genetic testing and analytics should be made available to all who need it, harnessing the power of

  • 23andMe signs Parkinson’s deal with Genentech 23andMe signs Parkinson’s deal with Genentech

    23andMe signs Parkinson’ s deal with Genentech. Adds to list of pharma tie-ups for genetic testing firm. ... The Google-backed genetic testing company 23andMe has penned a new research pact with Roche subsidiary Genentech.

  • VIDEO interview: Neil Weir, UCB VIDEO interview: Neil Weir, UCB

    According to Dr Weir, if a patient is taught about the basis of his disease, he is more willing to collaborate on the research side, providing blood or genetic testing at ... According to Dr Weir, by understanding the genetic make-up of patients with the

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • MDxHealth creates new global commercial team MDxHealth creates new global commercial team

    Swansiger becomes senior vice president of business development at the biotechnology company and brings over 15 years of experience in oncology and autoimmune genomic and genetic testing. ... Rentrop joins from Noviogendix, where he was responsible for

  • Sophia Genetics names Marylin Mermod Schule as CFO Sophia Genetics names Marylin Mermod Schule as CFO

    Commenting on her appointment, Marylin Mermod Schule said: “ Sophia Genetics stands out among its peers in Europe in the rapidly growing field of genetic data analysis. “ ... The growth of precision medicine and increasing public interest in the

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Personas: a top tool for personalising pharma marketing campaigns

    From health apps, such as the UK National Health Service and Babylon’ s GP at Hand, to the novel ease of genetic testing, patients now have a greater ability to monitor

  • 23andMe – is DNA screening ethical?

    With NHS England launching a new programme to test innovative ways of diagnosing cancer more quickly at over 60 sites across the country, you wonder if genetic testing is the key ... Newborn screening can identify genetic disorders early in life so

  • Big data, privacy and the rise of genomic testing

    Now, organisations such as 23andMe are offering genetic testing and analysis to the public for less than £150, while BGI offers scientific grade Whole Genome Sequencing for as little as $600 ... There are  more than 5, 000 rare genetic diseases, which

  • Lynch syndrome: a patient perspective

    Diagnosis of Lynch syndrome is achieved through genetic testing on a tissue sample (biopsy) or on blood targeting the aforementioned genes. ... If a genetic test is positive, the patient will have to increase the frequency of regular bowel screening.

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

Transforming healthcare through effective collaboration. Making work to feel proud of. www.dovetailstrategies.com...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics